(Presolicitation Notice) Intent to Sole Source - BioRad Antibodies
Key Takeaways
- Set-aside for No Set Aside businesses
- Work to be performed in ATLANTA, GA
- Industry: Biological Product (except Diagnostic) Manufacturing
- Advance notice of upcoming solicitation
Contract Details
- Notice ID
- PR-95570
- Opportunity Type
- Presolicitation
- Sub-Agency
- CENTERS FOR DISEASE CONTROL AND PREVENTION
- Office
- CDC OFFICE OF ACQUISITION SERVICES
- Posted Date
- Friday, July 17, 2026
- Response Deadline
- Saturday, August 1, 2026
- PSC Code
- 6640
- Set-Aside
- No Set Aside
- Place of Performance
- ATLANTA, GA, 30333
- Status
- Active
Description
NOTICE OF INTENT TO AWARD A SOLE SOURCE ACTION to BIORAD Laboratories, for the acquisition of: BIORAD Antibodies This procurement action is being conducted under the authority of FAR 12.201-1, Simplified procedures, in accordance with Federal Acquisition Regulation (FAR) Procedures for Evaluation and Solicitation for Commercial Items, in conjunction with the policies and procedures for solicitation, evaluation, and award as prescribed in FAR 12.102 Restricting competition. This Notice of Intent is not a request for Proposals or Quotations. No solicitation document exists, and no telephone or email inquiries will be accepted. No contract award will be made based on proposals, or quotations received in response to this notice. Interested persons may identify their interest and capability to
Why This Opportunity Matters
HEALTH AND HUMAN SERVICES, DEPARTMENT OF is actively seeking qualified contractors for biological product (except diagnostic) manufacturing with a set-aside for No Set Aside businesses in ATLANTA, GA. This set-aside designation means eligible businesses face reduced competition from larger firms.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts
